Vodafone Idea shares up 14% in four sessions as Street awaits clarity on AGR dues
Vodafone Idea clarified it hasn’t received any communication from the government regarding the relief of ₹84,000 crore.
Uncategorized
Lupin receives US FDA approval for drug used to treat bowel disorder
According to the IQVIA data dated April 2025, the tablets had an estimated annual sales of $184 million in the US market.
Vodafone Idea may stay in the game but don’t expect a turnaround: IIFL Capital
Balaji Subramanian, Vice President of IIFL Capital Services, expects the next round of telecom tariff hikes towards the end of 2025 or early 2026.
Reliance Industries shares gain after CLSA sees 16% upside; Citi raises price target
Reliance Industries’ annual general meeting, which is likely to be held in August or September, should be an important event which may hold hints for an upcoming Jio IPO, as well as announcements on scaling up in quick commerce, FMCG…
Dixon Technologies shares fall after getting their second-lowest price target on increased competition
Motorola, Dixon’s largest client, has begun outsourcing domestic volumes to Karbonn. While Dixon was Motorola’s sole manufacturing partner in CY24, the trend shifted in CY25. In February and March, outsourcing was minimal, but by April-May, Karbonn accounted for 25% of…
Hyundai Motor India shareholders have reasons to cheer, eight months after listing
Out of the 24 analysts that have coverage on Hyundai Motor India, 20 of them have a “buy” rating on the stock, three say “hold” and one has a “sell” rating on India’s largest IPO.
M&G’s Pershad sees fund flows returning to India soon, favours these sectors
Vikash Pershad, Portfolio Manager for Asian Equities at M&G Investments, highlighted that nearly 75% of NSE 200 revenues comes from within India, compared to less than 60% for the S&P 500 in the US..
Adani, Vedanta, Dalmia among bidders for debt-laden Jaiprakash Associates as bid deadline closes
As per two people directly in the know, at least six bids have been received, with major names such as Adani Enterprises, Vedanta Group, Dalmia Bharat, and Jaypee Infratech (controlled by the Suraksha Group) likely among the contenders. Jindal Group…
Macquarie’s Bhatia says a 10% market correction wouldn’t be a bad thing
Sandeep Bhatia, Managing Director and Head of Equity India at Macquarie Capital, highlights Sun Pharma as a preferred pick, citing its ability to deliver consistent earnings growth while still trading at relatively reasonable valuations compared to peers. He also maintains…
Indian Oil, BPCL better placed to capitalise on better refining margins, UBS says
UBS said that Indian refiners have a product slate that is heavily skewed towards middle distillates, with yields at 53% for IOCL, 54% for BPCL, and 46% for HPCL.